Retatrutide

Weight Loss In Stock

Retatrutide

Triple GIP/GLP-1/Glucagon receptor agonist

$95.00
Dosage
5mg/vial
Packaging
1 vial
Purity
≥99%

Description
Retatrutide is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors. Currently one of the most studied compounds for metabolic research with unprecedented efficacy in preclinical models.



Every batch verified by third-party laboratory testing.
Quality Assurance
Purity Analysis — HPLC and Mass Spectrometry verified
Quantitative Testing — Accurate dosing confirmed
USP andlt;71andgt; Sterility — Screened for microbial contamination
Bacterial Endotoxin Panel — Free from harmful toxins
Heavy Metals Screening — Tested for contaminants